TY - JOUR
T1 - Effects of a new radio frequency-controlled neuroprosthesis on gait symmetry and rhythmicity in patients with chronic hemiparesis
AU - Hausdorff, Jeffrey M.
AU - Ring, Haim
PY - 2008/1
Y1 - 2008/1
N2 - OBJECTIVE: To assess the effects of a new neuroprosthesis (NESS L300) designed to ameliorate foot drop on gait symmetry and rhythmicity during walking. DESIGN: Twenty-four patients (mean age: 54.0 ± 13.5 yrs) with chronic hemiparesis (5.8 ± 5.2 yrs) whose walking was impaired by foot drop. Subjects walked for 6 mins while wearing force-sensitive insoles, once with and once without the neuroprosthesis, in randomized order. Additional assessments with the neuroprosthesis were conducted after using the device for 4 and 8 wks. Walking speed, swing, and stride time were determined, along with a gait asymmetry index and stride time variability-both markers of gait stability and fall risk. RESULTS: While wearing the neuroprosthesis, the gait asymmetry index instantly improved by 28% (from 0.58 ± 0.30 to 0.42 ± 0.22) and by 45% (to 0.32 ± 0.20; P < 0.001) after 8 wks. Stride time variability decreased by 23% immediately (from 5.7 ± 2.9% to 4.4 ± 1.3%) and by 33% (to 3.8 ± 1.4%; P = 0.002) after 8 wks. Walking speed improved initially by 17% (from 0.53 ± 0.24 to 0.62 ± 0.22 m/sec) and after 8 wks by 34% (to 0.71 ± 0.25 m/sec; P < 0.001). CONCLUSIONS: The studied neuroprosthesis enhances gait and improves dynamic stability in chronic hemiparetic patients, supporting the idea that this is a viable treatment option in the rehabilitation of patients with foot drop.
AB - OBJECTIVE: To assess the effects of a new neuroprosthesis (NESS L300) designed to ameliorate foot drop on gait symmetry and rhythmicity during walking. DESIGN: Twenty-four patients (mean age: 54.0 ± 13.5 yrs) with chronic hemiparesis (5.8 ± 5.2 yrs) whose walking was impaired by foot drop. Subjects walked for 6 mins while wearing force-sensitive insoles, once with and once without the neuroprosthesis, in randomized order. Additional assessments with the neuroprosthesis were conducted after using the device for 4 and 8 wks. Walking speed, swing, and stride time were determined, along with a gait asymmetry index and stride time variability-both markers of gait stability and fall risk. RESULTS: While wearing the neuroprosthesis, the gait asymmetry index instantly improved by 28% (from 0.58 ± 0.30 to 0.42 ± 0.22) and by 45% (to 0.32 ± 0.20; P < 0.001) after 8 wks. Stride time variability decreased by 23% immediately (from 5.7 ± 2.9% to 4.4 ± 1.3%) and by 33% (to 3.8 ± 1.4%; P = 0.002) after 8 wks. Walking speed improved initially by 17% (from 0.53 ± 0.24 to 0.62 ± 0.22 m/sec) and after 8 wks by 34% (to 0.71 ± 0.25 m/sec; P < 0.001). CONCLUSIONS: The studied neuroprosthesis enhances gait and improves dynamic stability in chronic hemiparetic patients, supporting the idea that this is a viable treatment option in the rehabilitation of patients with foot drop.
KW - Asymmetry
KW - Foot Drop
KW - Gait
KW - Gait Variability
KW - Neuroprosthesis
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=37549043507&partnerID=8YFLogxK
U2 - 10.1097/PHM.0b013e31815e6680
DO - 10.1097/PHM.0b013e31815e6680
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18158427
AN - SCOPUS:37549043507
SN - 0894-9115
VL - 87
SP - 4
EP - 13
JO - American Journal of Physical Medicine and Rehabilitation
JF - American Journal of Physical Medicine and Rehabilitation
IS - 1
ER -